disease activity and are likely to be taking immunosuppressant medications at the time of surgery, the management of which was felt to be beyond the scope of this guideline. This was the focus of the 2022 American College of Rheumatology (ACR)/American Association of Hip and Knee Surgeons (AAHKS) Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty METHODS This guideline follows the ACR guideline development process and ACR policy guiding management of conflicts of interest and disclosures https://rheumatology.org/clinicalpractice-guidelines Consensus required â‰¥70% agreement on both direction (for or against) and strength (strong or conditional) of each recommendation, as per ACR practice. A recommendation could be either in favor of or against the proposed intervention and either strong or conditional. According to GRADE, a recommendation was categorized as strong if the